
- /
- Supported exchanges
- / MU
- / XE9.MU
XENCOR (XE9 MU) stock market data APIs
XENCOR Financial Data Overview
There is no Profile data available for XE9.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get XENCOR data using free add-ons & libraries
Get XENCOR Fundamental Data
XENCOR Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
XENCOR News

RBC Cuts Xencor (XNCR) Price Target but Keeps Outperform Rating
Xencor, Inc. (NASDAQ:XNCR) is one of the Top 10 Stocks Under $10 That Could Triple. On August 21, RBC Capital reduced its price target for Xencor, Inc. (NASDAQ:XNCR) from $32 to $15 and maintained an ...


Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks retreated late Wednesday afternoon, with the NYSE Health Care Index down 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...

Sector Update: Health Care Stocks Retreat Wednesday Afternoon
Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index down 0.4% and the H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...

Xencor to Participate at Upcoming Investor Conferences
PASADENA, Calif., August 27, 2025--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune d...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.